Bronchodilator acutely reduces expiratory flow limitation during exercise in COPD demonstrated by dynamic hyperinflation, flow-volume curve analysis and impulse oscillometry
J. Porszasz (Torrance, United States of America), M. Cao (Beijing, China), F. Lin (Beijing, China), W. Yuan (Beijing, China), R. Calmelat (Torrance, United States of America), H. Rossiter (Torrance, United States of America), R. Casaburi (Torrance, United States of America), W. Stringer (Torrance, United States of America)
Source: Virtual Congress 2020 – From respiratory physiology to diagnosis and treatment
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Porszasz (Torrance, United States of America), M. Cao (Beijing, China), F. Lin (Beijing, China), W. Yuan (Beijing, China), R. Calmelat (Torrance, United States of America), H. Rossiter (Torrance, United States of America), R. Casaburi (Torrance, United States of America), W. Stringer (Torrance, United States of America). Bronchodilator acutely reduces expiratory flow limitation during exercise in COPD demonstrated by dynamic hyperinflation, flow-volume curve analysis and impulse oscillometry. 2556
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: